南方医科大学学报 ›› 2026, Vol. 46 ›› Issue (10): 2424-2433.doi: 10.12122/j.issn.1673-4254.2026.10.12
• • 上一篇
黄莹莹1,2(
), 吴玮1,2(
), 洪小颖1,2, 江贤栋1,2, 薛龑1,2(
), 林东红1,2(
)
收稿日期:2026-04-24
出版日期:2026-10-20
发布日期:2026-10-26
通讯作者:
薛龑,林东红
E-mail:xxx810310@163.com;914525752@qq.com;XY0804@139.com;lindh65@163.com
作者简介:黄莹莹,在读博士研究生,E-mail: xxx810310@163.com基金资助:
Yingying HUANG1,2(
), Wei WU1,2(
), Xiaoying HONG1,2, Xiandong JIANG1,2, Yan XUE1,2(
), Donghong LIN1,2(
)
Received:2026-04-24
Online:2026-10-20
Published:2026-10-26
Contact:
Yan XUE, Donghong LIN
E-mail:xxx810310@163.com;914525752@qq.com;XY0804@139.com;lindh65@163.com
Supported by:摘要:
目的 明确参与调控二高-γ-亚麻酸(DGLA)诱导急性髓系白血病(AML)细胞铁死亡的潜在靶基因,探讨其对DGLA诱导的AML细胞铁死亡的影响。 方法 将BALB/c裸鼠分为DGLA组和Vehicle组,6只/组,接种THP-1细胞建立AML皮下荷瘤模型,DGLA组给予DGLA灌胃处理,Vehicle组以等量溶剂作对照。监测肿瘤生长并检测铁死亡指标以鉴定体内铁死亡模型。采用RNA-seq结合FerrDb数据库,筛选调控DGLA诱导AML细胞铁死亡的相关靶基因并进行qRT-PCR验证。构建靶基因下调的AML细胞系,结合体外细胞实验与体内荷瘤模型,评估靶基因下调联合DGLA处理对AML细胞、移植瘤表型及铁死亡相关指标的影响。 结果 成功建立铁死亡AML细胞皮下荷瘤模型,DGLA组小鼠肿瘤体积及质量减小(P<0.01),瘤体组织AML细胞线粒体可见体积缩小、外膜破裂等铁死亡性结构破坏,ROS、MDA和Fe2+水平升高(P<0.01),TfR1和PTGS2的mRNA和蛋白表达水平升高(P<0.05)。FerrDb数据库与脂质代谢通路基因联合分析,发现鞘磷脂磷酸二酯酶1(SMPD1)上调(P<0.001)。SMPD1下调的THP-1细胞经DGLA干预后,细胞活力明显减弱(P<0.01),线粒体铁死亡性破坏加剧,ROS、MDA和Fe2+水平升高(P<0.01),抗氧化防御关键分子GPX4和SLC7A11蛋白水平下调(P<0.05)。体内动物实验表明,shRNA组小鼠经DGLA处理后,肿瘤体积和质量均减小(P<0.01),MDA、ROS和Fe2+升高(P<0.01),TfR1和PTGS2表达水平升高(P<0.05)。 结论 下调SMPD1可促进DGLA诱导的体内外AML细胞铁死亡,抑制AML细胞活力。
黄莹莹, 吴玮, 洪小颖, 江贤栋, 薛龑, 林东红. 干扰鞘磷脂磷酸二酯酶1促进外源性二高-γ-亚麻酸诱导的急性髓系白血病细胞铁死亡[J]. 南方医科大学学报, 2026, 46(10): 2424-2433.
Yingying HUANG, Wei WU, Xiaoying HONG, Xiandong JIANG, Yan XUE, Donghong LIN. Sphingomyelin phosphodiesterase 1 knockdown promotes exogenous dihomo-γ-linolenic acid-induced ferroptosis in acute myeloid leukemia cells[J]. Journal of Southern Medical University, 2026, 46(10): 2424-2433.
| Primer name | Sequences(5'-3') |
|---|---|
| β-actin-F | TGACGTGGACATCCGCAAAG |
| β-actin-R | CTGGAAGGTGGACAGCGAGG |
| TfR1-F | GGCTACTTGGGCTATTGTAAAGG |
| TfR1-R | CAGTTTCTCCGACAACTTTCTCT |
| PTGS2-F | CTGGCGCTCAGCCATACAG |
| PTGS2-R | CGCACTTATACTGGTCAAATCCC |
| SMPD1-F | CAGGTATGAGAACACCCTGGC |
| SMPD1-R | CCGATGTAGGTAGTTGCACTG |
表1 引物序列
Tab.1 Primer sequences
| Primer name | Sequences(5'-3') |
|---|---|
| β-actin-F | TGACGTGGACATCCGCAAAG |
| β-actin-R | CTGGAAGGTGGACAGCGAGG |
| TfR1-F | GGCTACTTGGGCTATTGTAAAGG |
| TfR1-R | CAGTTTCTCCGACAACTTTCTCT |
| PTGS2-F | CTGGCGCTCAGCCATACAG |
| PTGS2-R | CGCACTTATACTGGTCAAATCCC |
| SMPD1-F | CAGGTATGAGAACACCCTGGC |
| SMPD1-R | CCGATGTAGGTAGTTGCACTG |
图1 AML细胞皮下荷瘤模型建立
Fig.1 Establishment of nude mouse models bearing subcutaneous AML cell xenograft. A: Mouse grouping of subcutaneous xenograft model. B: Dissected tumors from DGLA and vehicle groups. C: Tumor volume in DGLA and vehicle groups. D: Tumor weight changes in DGLA and vehicle groups. **P<0.01, ***P<0.001 vs vehicle group, n=6.
图2 DGLA诱导的AML细胞皮下瘤模型铁死亡指标检测
Fig.2 Detection of ferroptosis markers in subcutaneous xenografts derived from DGLA-induced AML cells. A: Flow histogram of lipid ROS levels. B: Quantitative result of ROS. C: Detection of MDA levels. D: Detection of Fe2+ levels. E: Changes of mitochondrial ultrastructural (Scale bar=1 μm). White arrows: normal mitochondria; red arrows: ferroptotic mitochondria; yellow arrows: lipid droplets. F, G: TfR1 and PTGS2 mRNA expression levels. H: TfR1 and PTGS2 protein blotting bands. I, J: TfR1 and PTGS2 protein expression levels. *P<0.05, **P<0.01, ***P<0.001 vs Vehicle group (n=6); n=3 for qRT-PCR and Western blotting analysis.
图3 RNA-seq联合FerrDb发现SMPD1显著上调
Fig.3 Significant upregulation of SMPD1 identified by RNA-seq combined with FerrDb analysis. A: PCA plot of RNA-seq. B: Bar chart of differentially expressed genes. C: Bubble chart depicting the KEGG enrichment of the differentially expressed genes. D: Heatmap of lipid metabolism. E: Venn diagram of lipid metabolism and FerrDb. F: Changes of SMPD1 mRNA level after DGLA treatment. **P<0.01 vs vehicle group (n=3).
图4 下调SMPD1增强DGLA对体外AML细胞活力的抑制作用
Fig.4 Downregulation of SMPD1 enhances DGLA-induced inhibition of AML cell viability in vitro. A, B: SMPD1 expression levels in THP-1 cells after lentiviral transfection. C: Effect of SMPD1 knockdown on THP-1 cell viability with DGLA treatment. **P<0.01 vs NC group, #P<0.001. n=3.
图5 下调SMPD1促进DGLA诱导的体外AML细胞铁死亡
Fig.5 SMPD1 knockdown promotes DGLA-induced ferroptosis in AML cells in vitro. A-D: Effect of SMPD1 knockdown on ROS, MDA and Fe2+ in THP-1 cells with DGLA treatment. E: Effect of SMPD1 knockdown on mitochondrial ultrastructure of THP-1 with DGLA treatment (Scale bar=1 μm). White arrows: normal mitochondria; red arrows: Ferroptotic mitochondria; yellow arrows: Lipid droplets. F-H: SLC7A11 and GPX4 protein expression levels. *P<0.05, **P<0.01, ***P<0.001 vs NC+DGLA group (n=3).
图6 下调SMPD1促进DGLA诱导的小鼠体内AML细胞铁死亡
Fig.6 SMPD1 knockdown promotes DGLA-induced ferroptosis of AML cells in mice. A: Observation of subcutaneous AML tumors in the mice. B: Dissected of subcutaneous tumors from each group. C: Tumor volume. D: Tumor weight. E: Mitochondrial ultrastructure in subcutaneous tumors from each group (Scale bar=1 μm). White arrows: Normal mitochondria; red arrows: Ferroptotic mitochondria; yellow arrows: Lipid droplets. F-I: ROS, MDA and Fe2+ levels. J-M: SMPD1, TfR1 and PTGS2 protein expression levels. *P<0.05, **P<0.01, ***P<0.001 vs NC+DGLA group. #P<0.05 vs NC+Vehicle group (n=6); n=3 per group for Western blotting analysis.
| [1] | Zhang SJ, Liu MH, Yao YF, et al. Targeting LSD1 for acute myeloid leukemia (AML) treatment[J]. Pharmacol Res, 2021, 164: 105335. doi:10.1016/j.phrs.2020.105335 |
| [2] | Haubner S, Subklewe M, Sadelain M. Honing CAR T cells to tackle acute myeloid leukemia[J]. Blood, 2025, 145(11): 1113-25. doi:10.1182/blood.2024024063 |
| [3] | Feng J, Li YL, He F, et al. RBM15 silencing promotes ferroptosis by regulating the TGF‑β/Smad2 pathway in lung cancer[J]. Environ Toxicol, 2023, 38(4): 950-61. doi:10.1002/tox.23741 |
| [4] | Yang C, Lu T, Liu M, et al. Tiliroside targets TBK1 to induce ferroptosis and sensitize hepatocellular carcinoma to sorafenib[J]. Phytomedicine, 2023, 111: 154668. doi:10.1016/j.phymed.2023.154668 |
| [5] | Yang F, Xiao Y, Ding JH, et al. Ferroptosis heterogeneity in triple-negative breast cancer reveals an innovative immunotherapy combination strategy[J]. Cell Metab, 2023, 35(1): 84-100.e8. doi:10.1016/j.cmet.2022.09.021 |
| [6] | Yang WS, SriRamaratnam R, Welsch ME, et al. Regulation of ferroptotic cancer cell death by GPX4[J]. Cell, 2014, 156(1/2): 317-31. doi:10.1016/j.cell.2013.12.010 |
| [7] | Dixon SJ, Lemberg KM, Lamprecht MR, et al. Ferroptosis: an iron-dependent form of nonapoptotic cell death[J]. Cell, 2012, 149(5): 1060-72. doi:10.1016/j.cell.2012.03.042 |
| [8] | Tousignant KD, Rockstroh A, Poad BLJ, et al. Therapy-induced lipid uptake and remodeling underpin ferroptosis hypersensitivity in prostate cancer[J]. Cancer Metab, 2020, 8(1): 11. doi:10.1186/s40170-020-00217-6 |
| [9] | Han JW, Zheng DH, Liu PS, et al. Peroxisomal homeostasis in metabolic diseases and its implication in ferroptosis[J]. Cell Commun Signal, 2024, 22(1): 475. doi:10.1186/s12964-024-01862-w |
| [10] | Turchi R, Tortolici F, Benvenuto M, et al. Low sulfur amino acid, high polyunsaturated fatty acid diet inhibits breast cancer growth[J]. Int J Mol Sci, 2022, 24(1): 249. doi:10.3390/ijms24010249 |
| [11] | Habib A, Mynott RL, Best OG, et al. Novel (1S, 3R)‑RSL3-encapsulated polyunsaturated fatty acid rich liposomes sensitise multiple myeloma cells to ferroptosis-mediated cell death[J]. Int J Mol Sci, 2025, 26(14): 6579. doi:10.3390/ijms26146579 |
| [12] | Nilsen DWT, Myhre PL, Kalstad A, et al. Serum levels of dihomo-gamma (γ)-linolenic acid (DGLA) are inversely associated with linoleic acid and total death in elderly patients with a recent myocardial infarction[J]. Nutrients, 2021, 13(10): 3475. doi:10.3390/nu13103475 |
| [13] | Perez MA, Magtanong L, Dixon SJ, et al. Dietary lipids induce ferroptosis in caenorhabditiselegans and human cancer cells[J]. Dev Cell, 2020, 54(4): 447-54.e4. doi:10.1016/j.devcel.2020.06.019 |
| [14] | Sarparast M, Pourmand E, Hinman J, et al. Dihydroxy-metabolites of dihomo‑γ‑linolenic acid drive ferroptosis-mediated neuro-degeneration[J]. ACS Cent Sci, 2023, 9(5): 870-82. doi:10.1021/acscentsci.3c00052 |
| [15] | Jiang XD, Huang YY, Hong XY, et al. Exogenous dihomo‑γ-linolenic acid triggers ferroptosis via ACSL4-mediated lipid metabolic reprogramming in acute myeloid leukemia cells[J]. Transl Oncol, 2025, 52: 102227. doi:10.1016/j.tranon.2024.102227 |
| [16] | Döhner H, Wei AH, Appelbaum FR, et al. Diagnosis and management of AML in adults: 2022 recommendations from an international expert panel on behalf of the ELN[J]. Blood, 2022, 140(12): 1345-77. doi:10.1182/blood.2022016867 |
| [17] | Kantarjian H, Kadia T, DiNardo C, et al. Acute myeloid leukemia: current progress and future directions[J]. Blood Cancer J, 2021, 11(2): 41. doi:10.1038/s41408-021-00425-3 |
| [18] | Kremer DM, Nelson BS, Lin L, et al. GOT1 inhibition promotes pancreatic cancer cell death by ferroptosis[J]. Nat Commun, 2021, 12(1): 4860. doi:10.1038/s41467-021-24859-2 |
| [19] | Yang JJ, Zhou YL, Xie SD, et al. Metformin induces Ferroptosis by inhibiting UFMylation of SLC7A11 in breast cancer[J]. J Exp Clin Cancer Res, 2021, 40(1): 206. doi:10.1186/s13046-021-02012-7 |
| [20] | Peng YX, Li N, Tang FF, et al. Corosolic acid sensitizes ferroptosis by upregulating HERPUD1 in liver cancer cells[J]. Cell Death Discov, 2022, 8(1): 376. doi:10.1038/s41420-022-01169-0 |
| [21] | Mustonen AM, Nieminen P. Dihomo‑γ-linolenic acid (20: 3n-6)-metabolism, derivatives, and potential significance in chronic inflammation[J]. Int J Mol Sci, 2023, 24(3): 2116. doi:10.3390/ijms24032116 |
| [22] | Stockwell BR, Jiang XJ, Gu W. Emerging mechanisms and disease relevance of ferroptosis[J]. Trends Cell Biol, 2020, 30(6): 478-90. doi:10.1016/j.tcb.2020.02.009 |
| [23] | Zhou N, Yuan XQ, Du QS, et al. FerrDb V2: update of the manually curated database of ferroptosis regulators and ferroptosis-disease associations[J]. Nucleic Acids Res, 2023, 51(D1): D571-82. doi:10.1093/nar/gkac935 |
| [24] | Huang ZW, Li M, Gu BY, et al. Ferroptosis-related LINC02535/has-miR-30c-5p/EIF2S1 axis as a novel prognostic biomarker involved in immune infiltration and progression of PDAC[J]. Cell Signal, 2024, 123: 111338. doi:10.1016/j.cellsig.2024.111338 |
| [25] | Yang ZW, Han TX, Yang RB, et al. Dicoumarol sensitizes hepatocellular carcinoma cells to ferroptosis induced by imidazole ketone erastin[J]. Front Immunol, 2025, 16: 1531874. doi:10.3389/fimmu.2025.1531874 |
| [26] | Qin JK, Li ZD, Su LZ, et al. Expression of transferrin receptor/TFRC protein in bladder cancer cell T24 and its role in inducing iron death in bladder cancer[J]. Int J Biol Macromol, 2024, 274(Pt 1): 133323. doi:10.1016/j.ijbiomac.2024.133323 |
| [27] | Ma HD, Wang XD, Zhang WL, et al. Melatonin suppresses ferroptosis induced by high glucose via activation of the Nrf2/HO-1 signaling pathway in type 2 diabetic osteoporosis[J]. Oxid Med Cell Longev, 2020, 2020(1): 9067610. doi:10.1155/2020/9067610 |
| [28] | Chen X, Tsvetkov AS, Shen HM, et al. International consensus guidelines for the definition, detection, and interpretation of autophagy-dependent ferroptosis[J]. Autophagy, 2024, 20(6): 1213-46. doi:10.1080/15548627.2024.2319901 |
| [29] | Ye Z, Xie B, Tao YG, et al. Mechanism of ferroptosis and its role in disease development[J]. Int J Biol Sci, 2025, 21(12): 5328-60. doi:10.7150/ijbs.102859 |
| [30] | Feng HZ, Schorpp K, Jin J, et al. Transferrin receptor is a specific ferroptosis marker[J]. Cell Rep, 2020, 30(10): 3411-23.e7. doi:10.1016/j.celrep.2020.02.049 |
| [31] | Kong ZY, Liu R, Cheng YR. Artesunate alleviates liver fibrosis by regulating ferroptosis signaling pathway[J]. Biomed Pharmacother, 2019, 109: 2043-53. doi:10.1016/j.biopha.2018.11.030 |
| [32] | Luo SM, Luo Y, Wang ZM, et al. Super-enhancer mediated upregulation of MYEOV suppresses ferroptosis in lung adenocarcinoma[J]. Cancer Lett, 2024, 589: 216811. doi:10.1016/j.canlet.2024.216811 |
| [33] | Dixon SJ, Pratt DA. Ferroptosis: a flexible constellation of related biochemical mechanisms[J]. Mol Cell, 2023, 83(7): 1030-42. doi:10.1016/j.molcel.2023.03.005 |
| [34] | Aldrovandi M, Fedorova M, Conrad M. Juggling with lipids, a game of Russian roulette[J]. Trends Endocrinol Metab, 2021, 32(7): 463-73. doi:10.1016/j.tem.2021.04.012 |
| [35] | Thayyullathil F, Cheratta AR, Alakkal A, et al. Acid sphingomyelinase-dependent autophagic degradation of GPX4 is critical for the execution of ferroptosis[J]. Cell Death Dis, 2021, 12: 26. doi:10.1038/s41419-020-03297-w |
| [36] | Guo C, Liao KQ, Chen GL, et al. SMPD1 modulates malignant progress of osteosarcoma through ferroptosis pathway[J]. Tissue Cell, 2026, 102: 103588. doi:10.1016/j.tice.2026.103588 |
| [37] | Sokol KH, Lee CJ, Rogers TJ, et al. Lipid availability influences ferroptosis sensitivity in cancer cells by regulating polyunsaturated fatty acid trafficking[J]. Cell Chem Biol, 2025, 32(3): 408-22.e6. doi:10.1016/j.chembiol.2024.09.008 |
| [1] | 祁春晖, 张鹤骞, 吴晓爽, 康永安, 杨静怡, 赵迪, 高社干, 齐义军. PSME2和STAT3双重抑制通过调控SLC7A11/GPX4轴诱导食管鳞癌细胞铁死亡[J]. 南方医科大学学报, 2026, 46(9): 2230-2241. |
| [2] | 何丽玲, 吴丹, 赖碧璇, 牛绮萱, 陈俊华, 高建红, 龙清华, 王政喻. 无忧汤通过激活Nrf2/HO-1通路抑制铁死亡减轻慢性睡眠剥夺模型大鼠海马神经元损伤并改善突触可塑性[J]. 南方医科大学学报, 2026, 46(8): 1754-1763. |
| [3] | 王坤, 侯顺福, 李勇, 刘清华, 尹崇高, 李洪利. miR-183-5p通过靶向调控KLHL24影响三阴性乳腺癌细胞增殖、侵袭、迁移及铁死亡[J]. 南方医科大学学报, 2026, 46(8): 1790-1798. |
| [4] | 杨继苹, 顾永增, 傅振燚, 董乐馨, 邓仪昊, 李正, 刘良丽, 郭涛. 天麻素经P53/SLC7A11/GPX4信号轴抑制神经元铁死亡减轻高原低压缺氧性脑损伤[J]. 南方医科大学学报, 2026, 46(7): 1498-1508. |
| [5] | 祝金超, 邵宁宁, 黄泽彧, 刘燕青, 孟祥艳, 刘子泉, 孙予杰, 董津睿, 樊毫军. 薤白超细粉通过抑制铁死亡并调控NF-κB/STAT3信号轴缓解脂多糖诱导的小鼠急性肺损伤[J]. 南方医科大学学报, 2026, 46(5): 1006-1017. |
| [6] | 程园园, 黄传兵, 张娟, 朱雅文, 钱爱. 重骨颗粒通过调控Nrf2通路改善膝骨关节炎肝肾亏虚证患者的软骨损伤[J]. 南方医科大学学报, 2026, 46(5): 1028-1038. |
| [7] | 朱菲菲, 闫娜, 杨继文, 陈晓磊, 王莹莹. SENP1 通过调控HIF-1α减少甲状腺癌细胞铁死亡[J]. 南方医科大学学报, 2026, 46(5): 1093-1101. |
| [8] | 魏栋敏, 王冰冰, 高建忠, 翟天宇, 白心悦, 朱晶惠, 张灿, 施彩珍, 郝琴, 陈晨, 赵琳. miR-24-3p靶向GSK-3β抑制铁死亡促进大鼠脊髓损伤修复[J]. 南方医科大学学报, 2026, 46(4): 715-727. |
| [9] | 李云飞, 黄传兵, 庞利君, 朱子衡, 李明. 健脾滋肾方改善系统性红斑狼疮小鼠肾损害:基于p53-MDM2信号轴介导的铁死亡[J]. 南方医科大学学报, 2026, 46(4): 785-793. |
| [10] | 宋淇乐, 苗益恺, 冯小桐, 王一凡, 刘伟, 魏琪, 于新汝, 陈文文, 付晓艳. 硒代胱氨酸通过诱导活性氧产生启动氧化应激损伤抑制结肠癌细胞生长[J]. 南方医科大学学报, 2026, 46(3): 532-540. |
| [11] | 郭涛, 陈柏霖, 杨逍, 赵艳丽, 李晓敏, 何佳浩, 石金沙, 左涵珺, 李娟娟. 刺芒柄花素通过下调P53/SAT1/ACSL4介导的铁死亡改善新生小鼠缺氧缺血性脑损伤[J]. 南方医科大学学报, 2026, 46(3): 604-614. |
| [12] | 郭涛, 何佳浩, 董乐馨, 王朝, 左涵珺, 赵艳丽, 石金沙, 赵敏, 李娟娟. 五味子醇甲通过抑制ACSL4/TFRC/PTGS2信号通路缓解缺氧缺血性脑损伤小鼠神经元铁死亡[J]. 南方医科大学学报, 2026, 46(10): 2393-2404. |
| [13] | 何榕茂, 方泽扬, 张芸芸, 吴友谅, 梁世秀, 计涛, 陈科全, 王斯琪. 铁死亡相关基因对溃疡性结肠炎具有诊断预测价值[J]. 南方医科大学学报, 2025, 45(9): 1927-1937. |
| [14] | 云琦, 杜若丽, 贺玉莹, 张贻欣, 王佳慧, 叶红伟, 李正红, 高琴. 肉桂酸通过抑制TLR4减轻阿霉素诱导的小鼠心肌损伤铁死亡的发生[J]. 南方医科大学学报, 2025, 45(9): 1946-1958. |
| [15] | 欧泽金, 李瀛, 陈诗, 王梓译, 何美仪, 陈志成, 唐侍豪, 孟晓静, 王致. 抑制铁死亡减轻敌草快引起的斑马鱼急性肾损伤的机制[J]. 南方医科大学学报, 2025, 45(8): 1743-1750. |
| 阅读次数 | ||||||
|
全文 |
|
|||||
|
摘要 |
|
|||||